Concepedia

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

Sandro Pignata, Michael A. Bookman, Jalid Sehouli, Austin Miller, Richard T. Penson, Çağatay Taşkıran, Charles Anderson, Sakari Hietanen, Tashanna Myers, Radosław Mądry,

Gynecologic Oncology · 2023 · 27 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Nicoletta Colombo, Coraline Dubot, Domenica Lorusso et al. · New England Journal of Medicine · 2021 · 992 citations · Full text

, , +17

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

New England Journal of Medicine · 2022 · 893 citations · Full text

, , +8

Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care Clinics

Barbara A. Goff · JAMA · 2004 · 497 citations

, , +13

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro et al. · Journal of Clinical Oncology · 2019 · 483 citations · Full text

, , +12

Survival with Cemiplimab in Recurrent Cervical Cancer

New England Journal of Medicine · 2022 · 427 citations · Full text

, , +16